These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6188559)

  • 1. The excretion of human urinary kallikrein quantity and activity in normal and low renin subgroups of essential hypertension.
    Ura N; Shimamoto K; Nakao T; Ogasawara A; Tanaka S; Mita T; Nishimiya T; Iimura O
    Clin Exp Hypertens A; 1983; 5(3):329-37. PubMed ID: 6188559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of suppression of renal kallikrein activity in low renin essential hypertension and renoparenchymal hypertension.
    Shimamoto K; Masuda A; Ando T; Ura N; Nakagawa M; Mori Y; Nakagawa H; Sakakibara T; Ogata H; Iimura O
    Hypertension; 1989 Oct; 14(4):375-8. PubMed ID: 2676859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
    Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
    Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion of human urinary kallikrein quantity measured by a direct radioimmunoassay of human urinary kallikrein in patients with essential hypertension and secondary hypertensive diseases.
    Shimamoto K; Ura N; Tanaka S; Ogasawara A; Nakao T; Nakahashi Y; Chao J; Margolius HS; Iimura O
    Jpn Circ J; 1981 Sep; 45(9):1092-7. PubMed ID: 6913609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary kallikrein excretion and plasma renin activity in patients with essential hypertension and primary aldosteronism.
    Lechi A; Covi G; Lechi C; Corgnati A; Arosio E; Zatti M; Scuro LA
    Clin Sci Mol Med; 1978 Jul; 55(1):51-5. PubMed ID: 668267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aprotinin, a kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Bandiera F; Manunta P; Rubattu S; Rappelli A
    J Hypertens; 1987 Oct; 5(5):581-6. PubMed ID: 2448367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary kallikrein activity is not altered in human essential hypertension.
    Simonetti BM; Pierucci A; Taggi F; Morabito S; Vastano S; Marchetti S; Putini RL; Stirati G; Cinotti GA
    Uremia Invest; 1985-1986; 9(2):189-93. PubMed ID: 3915922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary kallikrein excretion in essential and mineralocorticoid hypertension.
    Holland OB; Chud JM; Braunstein H
    J Clin Invest; 1980 Feb; 65(2):347-56. PubMed ID: 7356684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
    Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
    Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ratio of active-to-total urinary kallikrein in essential hypertension.
    Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG
    Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
    Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():247s-250s. PubMed ID: 396074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary kallikrein in normal renin essential hypertension.
    Lawton WJ; Fitz AE
    Circulation; 1977 Nov; 56(5):856-9. PubMed ID: 912848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI; Matthews PG; Dax E
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of spironolactone on urinary kallikrein excretion in patients with essential hypertension and in primary aldosteronism.
    Seino M; Abe K; Sakurai Y; Irokawa N; Yasujima M; Chiba S; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1977 Feb; 121(2):111-9. PubMed ID: 847738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
    Nakahara M
    Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of renal kallikrein and prostaglandin in the control of renin release.
    Suzuki S; Kobayashi M; Hashiba K
    Jpn Heart J; 1986 Jan; 27(1):83-93. PubMed ID: 2425102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.